Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NICE rules on paclitaxel

The U.K.'s National Institute for Clinical Excellence (NICE), which advises Britain's National Health Service on the use of approved drugs, devices and procedures based on clinical and cost effectiveness, has determined that paclitaxel in combination with

Read the full 368 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers